Evidence mapPaperPMID 42001194Full record

ReviewDiabetology & metabolic syndrome2026

International consensus on adolescent metabolic health: prevention of obesity and type 2 diabetes.

Inass Shaltout, Peter Egbert Hermann Schwarz, Amr El-Meligi, Iman El Sherif, Hany Hammad, Shereen Abdelghaffar, Mona Hegazy, Gamela Nasr, Heba Habeeb, Engy Barakat and 11 more

Abstract readReview
In one paragraph

Review in Diabetology & metabolic syndrome, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

21 authors.

Inass ShaltoutInternal Medicine and Diabetes Department, Faculty of Medicine, Cairo University, Cairo, Egypt. Inassshaltout@hotmail.com.
Peter Egbert Hermann SchwarzDepartment for Prevention and Care of Diabetes, Faculty of Medicine, Carl Gustav Carus at the Technische Universität/TU Dresden, Dresden, Germany.
Amr El-MeligiInternal Medicine and Diabetes Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
Iman El SherifInternal Medicine Department, Endocrinology & Diabetes, Faculty of Medicine, Suez Canal University, Ismailia, Egypt.
Hany HammadInternal Medicine and Nephrology Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
Shereen AbdelghaffarDepartment of Pediatrics, Pediatric Diabetes and Endocrinology Unit, Faculty of Medicine, Cairo University, Cairo, Egypt.
Mona HegazyInternal Medicine Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
Gamela NasrDepartment of Cardiovascular Medicine, Suez Canal University, Cairo, Egypt.
Heba HabeebInternal Medicine and Diabetes Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
Engy BarakatInternal Medicine and Diabetes Department, Faculty of Medicine, Cairo University, Cairo, Egypt.
Tatjana MilenkovicFaculty of Medicine, University Clinic for Endocrinology, Diabetes and Metabolic Disorders, University Clinic for Endocrinology, Ss. Cyril and Methodius University in Skopje, Skopje, 1000, Republic of Macedonia.
Andrew J BehnkeChief Section of Endocrinology, Virginia Tech Carilion School of Medicine, Roanoke, VA, USA.
Mohamed HassaneinDepartment of Diabetes and Endocrinology, Mohamed Bin Rashid University, Dubai, UAE.
Jelica Bjekic MacutDepartment of Endocrinology, Faculty of Medicine, University Hospital Medical Center, University of Belgrade, Bezanijska kosa, Belgrade, Serbia.
Rajeev ChawlaNorth Delhi Diabetes Centre, DIPSI, New Delhi, India.
Shalini JaggiLifecare Diabetes Centre, New Delhi, India.
Jamal BelkadirDepartment of Endocrinology and Diabetes, Faculty of Medicine of Rabat, Rabat, Morocco.
Dario RahelićVuk Vrhovac University Clinic for DiabetesEndocrinology and Metabolic Diseases, Merkur University Hospital, Zagreb, Croatia.
Diop Said NorouFaculty of Medicine, National Diabetic Center, University of Dakar, Dakar, Senegal.
Florian TotiDepartment of Internal Medicine, University of Medicine, Tirana, Albania.
Amin Roshdy SolimanInternal Medicine and Diabetes Department, Faculty of Medicine, Cairo University, Cairo, Egypt.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThe global rise in adolescent obesity is driving an aggressive phenotype of type 2 diabetes (T2D), which is marked by rapid progression and premature mortality. Therefore, evidence-based, internationally applicable prevention guidelines are urgently needed.

methodsA multidisciplinary international panel (n = 21) developed consensus recommendations through a systematic literature review (utilizing Web of Science, Scopus, PubMed, Cochrane, and EMBASE for the years 2000–2025) and a structured meeting process (held from October 2024 to December 2025). Consensus required ≥ 80% agreement. A total of eighty statements were initially proposed, from which sixty achieved preliminary agreement in Phase 1. Following iterative refinement in Phases 2 and 3, fifty achieved final consensus, and thirty were eliminated, either for failing to achieve 80% agreement or by being designated for further research.

resultsThe panel established fifty evidence-based recommendations across nine domains, which include screening, lifestyle intervention, school-based initiatives, digital health, therapeutic options, and policy. Key recommendations are to implement standardized screening protocols in schools, regulate the advertising of unhealthy foods and beverages, promote healthy lifestyle trends through media, and integrate artificial intelligence (AI) to tailor prevention plans.

conclusionThis consensus provides a practical, multisectoral framework for the global prevention of adolescent obesity and T2D, designed for application across healthcare, governmental, and non-governmental settings.

Indexed as

AdolescentsAnti-obesity MedicationsArtificial IntelligenceDigital Health.ObesityPrediabetesPreventionType 2 Diabetes

Identifiers

PMID42001194
PMCPMC13112707

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.